Acute coronary syndrome
Conditions
Interventions
Implement LDL cholesterol management using a standardized clinical pathway and conduct familial hypercholesterolemia screening, considering genetic testing as needed.
Sponsors
Tada Hayato
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients hospitalized for acute coronary syndrome 2) Age 18 years or older 3) Written informed consent obtained from the patient voluntarily after providing sufficient informed consent regarding participation in this clinical study
Exclusion criteria
Exclusion criteria: 1) Patients who find it difficult to attend regular outpatient appointments 2) Patients who are pregnant or breastfeeding 3) Other patients deemed unsuitable for the program at the physician's discretion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Achievement of LDL cholesterol management target (<55 mg/dL) at 4 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Achievement of LDL cholesterol management target (< 55 mg/dL) at 12 weeks and 52 weeks. Achievement of LDL cholesterol management target (< 70 mg/dL) at 4 weeks, 12 weeks, and 52 weeks. Presence/absence of familial hypercholesterolemia diagnosis at 52 weeks. Cardiac events, safety (adverse events). | — |
Contacts
Public ContactYasuaki Takeji
Kanazawa University Hospital
Outcome results
None listed